The sensitivity of five tumor markers鈥擟EA, CYFRA21-1, NSE, pro-GRP, and CA125鈥攚as found to be <55%. This study revealed that a single tumor marker had limited value in lung cancer screening. However, combining two or more markers yielded varying area under the ...
上海玉博生物科技有限公司 主要致力于“Human tumor marker DR-70 for lung cancer,DR-70TM ELISA Kit ”的生产销售。多年的“Human tumor marker DR-70 for lung cancer,DR-70TM ELISA Kit ”生产与销售的经验,与各行业新老用户建立了稳定的合作关系,我公司经营的产品名
Four tumor markers,CA 125 ,CA 153 ,CA 199 and CEA are studied for their relations with lung cancer,using Respiratory Inflammatory Diseases,RIDs (bronchitis,bronchiectasis and pneumonia)as control.The result shows that the serum levels of CA 125 ,CA 153 ,CA 199 and CEA are significantly highe...
公开/公告号: CA2195403A1 公开/公告日期: 1996-02-01 申请(专利权)人: CYTOCLONAL PHARMACEUTICS, INC.发明人:RM Torczynski,AP Bollon 摘要: The present invention discloses an isolated and purified nucleic acid sequence and corresponding amino acid sequence to a novel protein specific for human lung...
Identification of lung tumor markers; Association of a pleural neoplastic involvement to an increase of CA 125 tumor associated antigen outcome; Results of marker tests.BuccheriG.FerrignoD.EBSCO_AspBritish Journal of CancerBuccheri G,Ferrigno D. Lung tumour markers in oncology practice: a study of ...
近年来发现了许多血清肿瘤标记物与乳腺癌相关,如MCA,CA15-3,CAM26,CAM29,CA549,CA27.29等[1~3],但其诊断敏感性和特异性不够理想.为此,我们选择了CA15-3,CA19-9,CA24-2... 宋现让,王丽莉,丁艳涛,... - 《癌症》 被引量: 0发表: 2001年 Significance of serum tumor markers carcinoembryonic antigen, ...
CA Cancer J Clin, 71 (2021), pp. 209-249 Google Scholar 11 W.D. Travis, H. Asamura, A.A. Bankier, et al. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition...
Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis CEA, CA 125, SCC, CYFRA 21-1 and NSE were prospectively studied in 211 patients with non-small cell lung cancer and compared with clinical...
ORIGINALARTICLEDiagnosticRoleofTumourMarkersCEA,CA15-3,CA19-9andCA125inLungCancerIndranathGhosh•DebojyotiBhattacharjee•AnjanKumarDas•Gou..
[87,88]. CAR-T cells targeting MUC1 successfully eliminate NSCLC tumor cells [88] and are evaluated in clinical trials for lung cancer (NCT03525782, NCT02587689, and NCT05239143). A third-generation anti-PSCA/MUC1/TGFβ/HER2/Mesothelin/Lewis-Y/GPC3/AXL/EGFR/B7-H3/Claudin18.2-CAR-T has...